Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Zhejiang Huahai Pharmaceutical Co. Ltd. is managing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 3 distinct examiners within 1 distinct art unit. KRISTEN WANG ROMERO is the busiest examiner, handling 1 pending office action. The concentration in 1 distinct art unit suggests a focused technical scope. However, the involvement of 3 distinct examiners means that each case is being reviewed by a different person. Practitioners should prepare for different examiner perspectives despite the shared art unit for these 3 pending office actions.
The 1 distinct art unit indicates that the 3 pending office actions are technically related within the Biotechnology & Pharmaceuticals sector. KRISTEN WANG ROMERO is the busiest examiner with 1 pending office action, which is one-third of the current pending workload. Each of the 3 pending office actions is assigned to a different one of the 3 distinct examiners. This structure requires practitioners to manage 3 separate examiner relationships. While the art unit remains constant, the 3 distinct examiners may have varying interpretations of the technology. Practitioners must tailor their approach for each of the 3 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROMERO, KRISTEN WANG | 1 | 68.8% | +31.9% |
| ARCORIA, PAUL JOSEPH | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864955 | METHOD FOR PREPARING GLUCOPYRANOSYL-CONTAINING COMPOUND | ROMERO, KRISTEN WANG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864955 | METHOD FOR PREPARING GLUCOPYRANOSYL-CONTAINING COMPOUND | ROMERO, KRISTEN WANG | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18864955 | METHOD FOR PREPARING GLUCOPYRANOSYL-CONTAINING COMPOUND | ROMERO, KRISTEN WANG | — | §102§103 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18850001 | METHOD FOR PURIFYING LEVETIRACETAM INTERMEDIATE | ARCORIA, PAUL JOSEPH | — | §103 | Non-Final OA | — | Pending | Sep 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial